), e57218. 27. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Canc Res. 2005;11(20):7490. 28. Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, et al. Curcumin inhibits tumor development and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Canc Res. 2007;13(11):34230. 29. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer via suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene items. Cancer Res. 2007;67(eight):38531. 30. Shakibaei M, Buhrmann C, Kraehe P, Shayan P, Lueders C, Goel A. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.NF-κB-IN-4 In Vivo PLoS One.Melittin Autophagy 2014;9(1), e85397. 31. Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M. Curcumin suppresses crosstalk in between colon cancer stem cells and stromal fibroblasts inside the tumor microenvironment: potential part of EMT. PLoS One particular. 2014;9(9), e107514. 32. Chen L, Li WF, Wang HX, Zhao HN, Tang JJ, Wu CJ, et al. Curcumin cytotoxicity is enhanced by PTEN disruption in colorectal cancer cells. Planet J Gastroenterol. 2013;19(40):68144. 33. Toden S, Okugawa Y, Jascur T, Wodarz D, Komarova NL, Buhrmann C, et al. Curcumin mediates chemosensitization to 5-fluorouracil through miRNAinduced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Carcinogenesis. 2015;36(3):3557. 34. Rana C, Piplani H, Vaish V, Nehru B, Sanyal SN. Downregulation of PI3-K/Akt/ PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer. Mol Cell Biochem. 2015;402(1):2251. 35. Zheng A, Li H, Wang X, Feng Z, Xu J, Cao K, et al. Anticancer impact of a curcumin derivative B63: ROS production and mitochondrial dysfunction. Curr Cancer Drug Targets. 2014;14(two):1566. 36. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury:37. 38. 39. 40. 41. 42.43.44. 45.46.47.48. 49.50. 51.52.53.54.55.56.57.58.59.pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl):1995025. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical tactics. Nat Rev Cancer. 2003;3(5):330. Benson 3rd AB. New approaches for the adjuvant therapy of colon cancer. Oncologist. 2006;11(9):9730. Pin AL, Houle F, Huot J.PMID:35116795 Current advances in colorectal cancer analysis: the microenvironment impact. Can Microenvironment. 2011;4(2):1271. Ohtsu A. Chemotherapy for metastatic gastric cancer: previous, present, and future. J Gastroenterol. 2008;43(4):2564. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):2259. Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP. Elimination of Colon Cancer Stem-Like Cells by the Mixture of Curcumin and FOLFOX. Transl Oncol. 2009;2(four):321. Berthiaume F, Moghe PV, Toner M, Yarmush ML. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured inside a sandwich configuration. FASEB J. 1996;ten(13):14714. Bissell.
